ALKEM.NS
Alkem Laboratories Limited$5,373.50
+0.44%Jun 19, 2026
Market cap
$642.48B
52w range
—
P / E
—
EPS · FY 2026
$192.51
Volume
—
Revenue · FY 2026
$147.12B
Explain this page
Arphra AIPlain-English read on Alkem Laboratories Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$4,230.50
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →ALKEM.NS
5,374+12.89%H 5,934L 4,716MA50 5,425MA200 5,518Avg vol 138K
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-0.91%
- Electronic Gaming & Multimedia+7.50%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Oil & Gas Energy-4.86%
- Consulting Services-4.82%
- Grocery Stores-4.35%
- Computer Hardware-3.67%
- Coal-3.56%
- Other Precious Metals-3.55%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for ALKEM.NS.
Peers
No peer list available for ALKEM.NS.
Total assets
$208.73B
Total debt
$20.47B
Cash & equiv
$2.48B
Operating CF
$19.63B
Free cash flow
$13.46B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $147.12B | $26.23B | $23.02B | $192.51 | +15.65% |